HC Wainwright Forecasts Strong Price Appreciation for Nuvation Bio (NYSE:NUVB) Stock
Nuvation Bio (NYSE:NUVB – Free Report) had its price objective upped by HC Wainwright from $10.00 to $11.00 in a research ...
HC Wainwright Analysts Boost Earnings Estimates for Evolus
Stock analysts at HC Wainwright upped their Q4 2024 earnings per share (EPS) estimates for Evolus in a report issued on Wednesday, January 22nd. HC Wainwright analyst D. Tsao now expects that the ...
Hosted on MSN3d
HC Wainwright & Co. Initiates Coverage of Worksport (WKSP) with Buy Recommendation
Fintel reports that on January 23, 2025, HC Wainwright & Co. initiated coverage of Worksport (NasdaqCM:WKSP) with a Buy recommendation. Analyst Price Forecast Suggests 59.38% Upside As of December 23, ...
H.C. Wainwright Reaffirms Their Buy Rating on Eton Pharmaceuticals (ETON)
In a report released today, Swayampakula Ramakanth from H.C. Wainwright maintained a Buy rating on Eton Pharmaceuticals (ETON – Research ...
Microbot Medical price target raised to $9 from $7 at H.C. Wainwright
H.C. Wainwright raised the firm’s price target on Microbot Medical (MBOT) to $9 from $7 and keeps a Buy rating on the shares. The firm believes ...
H.C. Wainwright cuts ALX Oncology target to $5, keeps buy rating
H.C. Wainwright analysts have reduced the price target for ALX Oncology (NASDAQ:ALXO) shares to $5 from the previous $25 ...
manilatimes5d
BTCS Inc. to Participate in Fireside Chat with Blockdaemon hosted by H.C. Wainwright
Charles Allen, CEO of BTCS, stated, " We are thrilled to collaborate with H.C. Wainwright and Freddy to share insights on the ...
ArriVent Biopharma price target raised to $39 from $36 at H.C. Wainwright
H.C. Wainwright raised the firm’s price target on ArriVent Biopharma (AVBP) to $39 from $36 and keeps a Buy rating on the ...
Monopar Therapeutics price target raised to $40 from $22 at H.C. Wainwright
H.C. Wainwright raised the firm’s price target on Monopar Therapeutics (MNPR) to $40 from $22 and keeps a Buy rating on the ...
Investing5d
H.C. Wainwright Reiterates Buy Rating on Axsome Shares
On Tuesday, H.C. Wainwright maintained a positive outlook on Axsome Therapeutics (NASDAQ:AXSM), reiterating a Buy stock rating with a price target of $180.00. According to InvestingPro data ...
bovnews4d
Why Did H.C. Wainwright Give Immunic Inc (IMUX) Stock Buy Rating?
Immunic Inc (IMUX) stock saw a modest uptick, ending the day at $0.95 which represents no change from the prior close of of $0.95. The stock opened at $0.98 and touched a low of $0.92 during the day, ...
Investing5d
H.C. Wainwright Reiterates Buy Rating on Axsome Shares
On Tuesday, H.C. Wainwright maintained a positive outlook on Axsome Therapeutics (NASDAQ:AXSM), reiterating a Buy stock rating with a price target of $180.00. According to InvestingPro data, this ...